It is thought that symptoms affecting terminally differentiated tissues in TTD patients are derived from gene expression problems due to TFIIH instability31 and that cancer predisposition in XP is caused by mutation accumulation due to reduced GG-NER activity27. Here, ERCC3 is linked to xeroderma pigmentosum.